Details for New Drug Application (NDA): 080017
✉ Email this page to a colleague
NDA 080017 describes FURALAN, which is a drug marketed by Chartwell Molecular and is included in one NDA. Additional details are available on the FURALAN profile page.
The generic ingredient in FURALAN is nitrofurantoin. There are twenty drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the nitrofurantoin profile page.
The generic ingredient in FURALAN is nitrofurantoin. There are twenty drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the nitrofurantoin profile page.
Summary for 080017
| Tradename: | FURALAN |
| Applicant: | Chartwell Molecular |
| Ingredient: | nitrofurantoin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 080017
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
